Medical Devices Startups
5,295 companies tagged Medical Devices, with their investors and founders.
Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis. The company produces medical devices for orthopedic shoulder procedures.
9 investors
Siren develops technology for early detection of diabetic foot ulcers to reduce injury risk. The company serves healthcare providers and patients managing diabetes.
9 investors
Subtle Medical develops deep learning software for medical imaging that enables faster and safer image acquisition on existing scanners for healthcare providers and imaging centers.
9 investors
Sully builds medical AI software for healthcare providers, including ambient documentation, scheduling, intake, and clinical decision support tools designed to reduce administrative burden and improve patient care efficiency.
9 investors
Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems. It serves researchers and cell and gene therapy developers in the biotechnology industry.
9 investors
SelfWrap develops bioabsorbable wrap materials for vascular grafts that conform to individual patient anatomy and are designed to be absorbed by the body, unlike alloy-based alternatives. The company is developing the product for coronary and peripheral bypass grafting applications.
9 investors
Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.
8 investors
ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers. Its pipeline centers on its lead candidate firmonertinib (formerly furmonertinib) and novel oncology therapeutics such as next-generation antibody drug conjugates.
8 investors
Ateios develops electrode manufacturing techniques designed to accelerate production speed, reduce carbon emissions, and decrease the physical footprint of battery manufacturing and gigafactories. The company provides advanced battery, materials, and software solutions to battery manufacturers.
8 investors
Avalyn Pharma is a clinical-stage biopharmaceutical company developing targeted inhaled therapies for patients with rare lung diseases, including pulmonary fibrosis and other interstitial lung diseases. Its lead inhaled therapies have advanced through global Phase 2 development for pulmonary fibrosis.
8 investors
Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases. The company works across multiple therapeutic areas to advance precision medicine treatments at the molecular level.
8 investors
Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device. It uses an on-device LED light system to signal glucose levels in real time and pairs with a mobile app that provides personalized health insights and trend tracking.
8 investors
Centaur.ai combines human medical professionals' assessments with AI algorithms to improve diagnostic accuracy for skin lesion evaluation and cancer detection. The platform weights opinions based on performance metrics to achieve results superior to either doctors or AI alone.
8 investors
Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies. The company serves cancer patients and their caregivers globally.
8 investors
Cooler Heads develops scalp cooling technology to prevent hair loss in cancer patients undergoing chemotherapy. The company manufactures the Amma scalp cooling system for oncology clinics and hospitals.
8 investors
Cortica provides in-home, in-clinic, and telehealth neurological therapies for children with autism and developmental differences, integrating neurological, biomedical, behavioral, speech-language, and sensorimotor treatments. The company serves families and children seeking developmental and learning acceleration.
8 investors
Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
8 investors
Forescout provides cyber-physical systems security and network access control solutions for IoT, OT, and medical device environments. The company serves enterprises managing IoT and industrial control system security risks.
8 investors
Genalyte is developing Merlin, an automated diagnostic device that processes blood samples on-site and returns lab results within minutes while the patient waits. Its CloudLab platform integrates with electronic medical record (EMR) systems to route and deliver results automatically at the point of care.
8 investors
8 investors
Heartbeat Health builds a modern cardiology ecosystem to deliver cardiovascular care through technology-enabled interventions. The company serves healthcare providers and patients seeking advanced cardiac care solutions.
8 investors
Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD). Its platform, Heartflow One, is used by cardiologists and clinicians to guide diagnosis and treatment decisions for patients.
8 investors
Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.
8 investors
Medisafe is a medication engagement platform that helps pharmaceutical companies connect with patients beyond the prescription and improve treatment adherence. The platform uses personalized, intelligent engagement to support patients with complex therapies across multiple therapeutic areas.
8 investors